Published in TB and Outbreaks Week, October 11th, 2005
The recent efforts were coled by Dr. Kim Lee Sim, president of Protein Potential LLC. Sim has worked for more than 15 years to develop this protein as a target for antimalaria vaccines and drugs. After cloning the gene for EBA175, she identified the regions of EBA-175 involved with the binding of this protein to the red blood cell, discovered the regions on the red cell that bind EBA-175, and demonstrated that antibodies against this portion of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week